IR@PKUHSC  > 北京大学临床肿瘤学院
学科主题临床医学
The short and long-term results of paclitaxel close escalating study concurrently with radiotherapy for Chinese patients with locally advanced non-small cell lung cancer after induction chemotherapy
Zhu, G. Y.; Shi, A. H.; An, T. T.; Yu, R.; Xu, G.; Liu, X. Y.; Xu, B.
刊名INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2006
suppl.S期:3页:S493-S494
收录类别ISTP ; SCI
文章类型Meeting Abstract
WOS标题词Science & Technology
类目[WOS]Oncology ; Radiology, Nuclear Medicine & Medical Imaging
研究领域[WOS]Oncology ; Radiology, Nuclear Medicine & Medical Imaging
语种英语
WOS记录号WOS:000241221602022
引用统计
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/56087
专题北京大学临床肿瘤学院
作者单位Peking Univ, Sch Oncol, Beijing 100036, Peoples R China
推荐引用方式
GB/T 7714
Zhu, G. Y.,Shi, A. H.,An, T. T.,et al. The short and long-term results of paclitaxel close escalating study concurrently with radiotherapy for Chinese patients with locally advanced non-small cell lung cancer after induction chemotherapy[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,2006,suppl.S(3):S493-S494.
APA Zhu, G. Y..,Shi, A. H..,An, T. T..,Yu, R..,Xu, G..,...&Xu, B..(2006).The short and long-term results of paclitaxel close escalating study concurrently with radiotherapy for Chinese patients with locally advanced non-small cell lung cancer after induction chemotherapy.INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,suppl.S(3),S493-S494.
MLA Zhu, G. Y.,et al."The short and long-term results of paclitaxel close escalating study concurrently with radiotherapy for Chinese patients with locally advanced non-small cell lung cancer after induction chemotherapy".INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS suppl.S.3(2006):S493-S494.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Zhu, G. Y.]的文章
[Shi, A. H.]的文章
[An, T. T.]的文章
百度学术
百度学术中相似的文章
[Zhu, G. Y.]的文章
[Shi, A. H.]的文章
[An, T. T.]的文章
必应学术
必应学术中相似的文章
[Zhu, G. Y.]的文章
[Shi, A. H.]的文章
[An, T. T.]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。